Two new Pew Latin American fellows, Beatriz De Moraes, PhD, and Lilian Gomes de Oliveira, PhD, will each receive a $30,000 annual stipend for two years to support their work at the crossroads of ...

A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.

Award-winning UCSF mentors Judith Hellman and Tor Neilands share their keys to success: deep commitment, individualized ...

A $100 million matching grant from the Weill Family Foundation is bringing together two leading cancer centers to launch the ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s, potentially slowing or even reversing its ...

The UCSF community is saddened at the passing of former UCSF faculty member William Rutter, PhD, whose collaborative and interdisciplinary research style helped guide the growth and quality of the ...

In one of the largest studies of its kind, researchers identified the U.S. regions where dementia occurs most often.

Researchers found that as preteens used more social media, their depressive symptoms increased. Yet the reverse wasn’t true — a rise in depressive symptoms didn’t predict a later increase in social ...

A first-of-its-kind study tested the safety of psilocybin on patients with mild to moderate Parkinson’s disease and found that patients experienced clinically significant improvements in mood, ...

The FDA has approved an adaptive deep brain stimulation (aDBS) treatment for people with with Parkinson’s disease, making this groundbreaking technology available to people nationwide.

Rates of advanced prostate cancer in California rose significantly in the decade since doctors stopped routinely screening all men. A UCSF study reinforces the need for screening that can identify ...